Publications by authors named "Benjamin N Greener"

Claim this Profile
A
ASCENIV utilization in a primary immunodeficiency patient with recurrent viral infections.
Kevin P Rosenbach, Benjamin N Greener, John T Rosenbach, Gene A Wetzstein

Immunol Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing process optimization of ADMA Biologics' intravenous immunoglobulin products, BIVIGAM and ASCENIV™.
Richard L Wasserman, Daniel Garcia, Benjamin N Greener, Kaitlin Kestenberg, Adam Pinkert

Immunotherapy· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
Richard L Wasserman, Benjamin N Greener, James Mond

Expert Rev Clin Immunol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single and multiple dose pharmacokinetics of dolutegravir in the genital tract of HIV-negative women.
Jessica L Adams, Kristine B Patterson, Heather M A Prince, Craig Sykes, Benjamin N Greener

Antivir Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir pharmacokinetics in the genital tract and colorectum of HIV-negative men after single and multiple dosing.
Benjamin N Greener, Kristine B Patterson, Heather M A Prince, Craig S Sykes, Jessica L Adams

J Acquir Immune Defic Syndr· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of HIV integrase inhibitors.
Jessica L Adams, Benjamin N Greener, Angela D M Kashuba

Curr Opin HIV AIDS· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
Iñigo Narvaiza, Daniel C Linfesty, Benjamin N Greener, Yoshiyuki Hakata, David J Pintel

PLoS Pathog· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis